XML 40 R28.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2021
Fair Value Disclosures [Abstract]  
Summary of Assets Measured at Fair Value on a Recurring Basis
The following tables present the Company’s assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2021 and December 31, 2020 (in thousands):
March 31, 2021
Total(Level 1)(Level 2)(Level 3)
Assets:
     Money market funds$58,158 $58,158 $— $— 
Marketable securities:
     Corporate bonds2,031 — 2,031 — 
     Commercial paper20,374 — 20,374 — 
Total assets$80,563 $58,158 $22,405 $— 
Liabilities:
     Warrant liabilities$45,455 $— $— $45,455 
Total liabilities$45,455 $— $— $45,455 
 
December 31, 2020
Total(Level 1)(Level 2)(Level 3)
Assets:
     Money market funds$80,576 $80,576 $— $— 
Total assets$80,576 $80,576 $— $— 
Liabilities:
     Warrant liabilities$28,708 $— $— $28,708 
Total liabilities$28,708 $— $— $28,708 
Schedule of Fair Value Measurement Inputs and Valuation Techniques
A summary of the Black-Scholes pricing model assumptions used to record the fair value of the warrant liability is as follows:
March 31,
 2021
Risk-free interest rate0.35 %
Dividend yield— 
Expected life (in years)3.73
Expected volatility101.13 %
Schedule Of Changes In The Warrant Liabilities
The following table reflects a roll-forward of fair value for the Company’s Level 3 warrant liabilities (see Note 10), for the three months ended March 31, 2021 (in thousands):
Warrant liabilities
Fair value as of December 31, 2020
$28,708 
     Change in fair value16,747 
Fair value as of March 31, 2021
$45,455 
Schedule of Cash and Cash Equivalents The Company’s consolidated statement of cash flows includes the following as of March 31, 2021 and 2020 (in thousands):
March 31,
20212020
Cash and cash equivalents$125,407 $72,606 
Short-term restricted cash— 279 
Long-term restricted cash1,379 1,379 
Total cash, cash equivalents, and restricted cash shown in the consolidated statement of cash flows$126,786 $74,264 
Schedule of Restricted Cash and Cash Equivalents The Company’s consolidated statement of cash flows includes the following as of March 31, 2021 and 2020 (in thousands):
March 31,
20212020
Cash and cash equivalents$125,407 $72,606 
Short-term restricted cash— 279 
Long-term restricted cash1,379 1,379 
Total cash, cash equivalents, and restricted cash shown in the consolidated statement of cash flows$126,786 $74,264